These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24790893)

  • 1. Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.
    Barar J; Omidi Y
    Bioimpacts; 2014; 4(1):3-14. PubMed ID: 24790893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in targeted therapy of cancer using graphene oxide-modified multifunctional nanomedicines.
    Rahmanian N; Eskandani M; Barar J; Omidi Y
    J Drug Target; 2017 Mar; 25(3):202-215. PubMed ID: 27646598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based multifunctional nanomedicines and theranostics for targeted therapy of cancer.
    Fathi M; Majidi S; Zangabad PS; Barar J; Erfan-Niya H; Omidi Y
    Med Res Rev; 2018 Sep; 38(6):2110-2136. PubMed ID: 29846948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled theranostics: magnetic and gold nanoparticles.
    Same S; Aghanejad A; Akbari Nakhjavani S; Barar J; Omidi Y
    Bioimpacts; 2016; 6(3):169-181. PubMed ID: 27853680
    [No Abstract]   [Full Text] [Related]  

  • 5. Impacts of quantum dots in molecular detection and bioimaging of cancer.
    Mashinchian O; Johari-Ahar M; Ghaemi B; Rashidi M; Barar J; Omidi Y
    Bioimpacts; 2014; 4(3):149-66. PubMed ID: 25337468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smart multifunctional theranostics: simultaneous diagnosis and therapy of cancer.
    Omidi Y
    Bioimpacts; 2011; 1(3):145-7. PubMed ID: 23678419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of blood-brain barrier in drug delivery and targeting of brain tumors.
    Omidi Y; Barar J
    Bioimpacts; 2012; 2(1):5-22. PubMed ID: 23678437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines.
    Islam R; Gao S; Islam W; Šubr V; Zhou JR; Yokomizo K; Etrych T; Maeda H; Fang J
    Acta Biomater; 2021 May; 126():372-383. PubMed ID: 33774199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting Nanomedicine Efficacy with Hyperbaric Oxygen Therapy.
    Wang X; Li S; Liu X; Wu X; Ye N; Yang X; Li Z
    Adv Exp Med Biol; 2021; 1295():77-95. PubMed ID: 33543456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive chitosan-based nanocarriers for cancer therapy.
    Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y
    Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene-based multifunctional nanosystems for simultaneous detection and treatment of breast cancer.
    Dolatkhah M; Hashemzadeh N; Barar J; Adibkia K; Aghanejad A; Barzegar-Jalali M; Omidi Y
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111104. PubMed ID: 32417466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicines in Diagnosis and Treatment of Cancer: An Update.
    Haider N; Fatima S; Taha M; Rizwanullah M; Firdous J; Ahmad R; Mazhar F; Khan MA
    Curr Pharm Des; 2020; 26(11):1216-1231. PubMed ID: 32188379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinspired and Biomimetic Nanomedicines.
    Chen Z; Wang Z; Gu Z
    Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific therapeutic aptamers for targeted therapy of cancer: a review on cellular perspective.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    J Mol Med (Berl); 2018 Sep; 96(9):885-902. PubMed ID: 30056527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.